AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
| MHJ | US Update | PRICE SENSITIVE | ||
| MHJ | Trading Update | PRICE SENSITIVE | ||
| MHJ | Market Update: Emma & Roe | PRICE SENSITIVE | ||
| MHJ US Update | |||
| 12/04/18 | PRICE SENSITIVE | ||
| MHJ Trading Update | |||
| 12/04/18 | PRICE SENSITIVE | ||
| MHJ Market Update: Emma & Roe | |||
| 06/03/18 | PRICE SENSITIVE | ||
